A randomized controlled trial found that people who drank kombucha daily experienced measurable declines in systolic and diastolic blood pressure, although researchers cautioned that larger and longer studies are needed before the fermented tea can be considered part of hypertension treatment.
By yourNEWS Media Newsroom.
Regular kombucha consumption was associated with reductions in both systolic and diastolic blood pressure in a recent randomized controlled trial, adding to scientific interest in whether fermented foods may influence cardiovascular health.
Participants who drank a specified amount of kombucha each day experienced average blood pressure declines that researchers characterized as clinically meaningful, according to the investigative report. The authors said the magnitude of the observed change was comparable to improvements sometimes associated with lifestyle measures such as increased exercise or dietary modification.
Researchers emphasized, however, that the findings remain preliminary. The trial involved a relatively small number of participants and followed them for only a limited period, preventing firm conclusions about kombucha’s long-term effects or its usefulness in treating hypertension.
The research team called for larger randomized studies with longer follow-up periods before the beverage is incorporated into cardiovascular treatment recommendations.
Kombucha, a fermented tea believed to have originated in China during the third century B.C., has been consumed for centuries. Modern interest in the drink has increasingly focused on its possible effects on chronic health conditions, including high blood pressure.
Study Design and Outcomes
Researchers conducted the investigation as a randomized controlled trial and tracked blood pressure changes among participants who consumed kombucha daily.
Those assigned to drink the fermented tea demonstrated decreases in both systolic pressure — the upper number in a blood pressure reading — and diastolic pressure, which represents pressure in the arteries between heartbeats.
The researchers described the average decline as potentially meaningful from a clinical perspective, but responses varied substantially among individual participants.
That variation may prove important in understanding why kombucha could affect some people differently from others.
Researchers proposed that differences in each participant’s gut microbiota could partly account for the uneven responses. Because kombucha contains microorganisms produced during fermentation, investigators said its interaction with the existing community of bacteria in a person’s digestive tract warrants closer study.
The trial’s limited size and duration remain significant constraints.
Researchers said the study was not large enough to adequately account for all variables that might influence blood pressure, while its short follow-up period left unanswered whether the effects would continue, diminish or change with prolonged consumption.
The authors therefore characterized the results as suggestive rather than conclusive and said additional controlled trials are necessary to determine whether the association can be reproduced.
Potential Mechanisms and Explanations
Researchers are examining several possible biological explanations for the observed blood pressure changes.
One hypothesis centers on kombucha’s polyphenols and probiotic content. Investigators said those components could potentially affect vascular function, including biological processes related to nitric oxide, which plays an important role in regulating blood vessel dilation and circulation.
Scientists have also increasingly studied the relationship between microorganisms in the digestive system and cardiovascular function, sometimes described as the gut-heart axis.
Previous animal research involving fermented tea has produced similar blood pressure-lowering effects, according to the report, providing one basis for investigating whether comparable mechanisms could operate in humans.
Researchers cautioned that such mechanisms have not yet been established.
It remains unclear whether the live microorganisms in kombucha, compounds derived from the tea itself, products created during fermentation or a combination of factors contributed to the results.
The interaction between kombucha’s microorganisms and an individual’s existing gut flora represents another unanswered question.
Investigators said additional studies will be needed to identify the particular compounds responsible for any cardiovascular effect and determine how they might influence the body’s systems for regulating blood pressure.
Reactions from the Health Community
Health professionals who were not involved in the research responded cautiously to the findings.
Some described the results as encouraging but said the available evidence remains insufficient to recommend kombucha as a treatment for hypertension.
Experts stressed that people with high blood pressure should not replace prescribed medications with the fermented beverage.
They also cautioned against assuming that all fermented foods or commercially produced kombucha products provide identical health effects.
Some commercial fermented products contain substantial quantities of added sugar or sodium. Excessive amounts of either could undermine efforts to improve cardiovascular health, depending on the product and a person’s overall diet.
The trial’s authors continued to emphasize established approaches to blood pressure control, including broader dietary and lifestyle measures, rather than presenting kombucha as a stand-alone intervention.
A representative of a major health charity declined to directly assess the study and said additional confirming evidence would be needed.
Kombucha Availability and Safety Considerations
Kombucha has become widely available in supermarkets and other retail stores as consumer interest in fermented foods has grown.
The beverage is generally produced by fermenting green, black or white tea with sugar and a culture containing bacteria and yeast.
Fermentation changes the tea’s chemical composition and can also generate small amounts of alcohol. Commercial kombucha is subject to federal requirements intended to keep its alcohol content within applicable limits unless it is regulated and sold as an alcoholic beverage.
Researchers advised people interested in consuming kombucha to pay attention to added sugar levels. Selecting lower-sugar varieties may help avoid offsetting potential dietary benefits with unnecessary sugar consumption.
Safety can also vary depending on how the beverage is produced.
Improperly prepared homemade kombucha has historically been associated with contamination concerns, making sanitation and proper brewing techniques important.
The authors also advised people with compromised immune systems or other health concerns to consult a health care professional before using kombucha specifically as a health intervention.
Looking Forward
The blood pressure findings are part of a larger scientific effort to understand whether fermented foods can influence chronic disease risk or management.
Researchers are studying not only kombucha but also yogurt, kefir and other cultured foods to determine how fermentation, microorganisms and resulting compounds may affect human physiology.
Interest in kombucha reflects broader investigation into whether dietary components can complement established strategies for maintaining cardiovascular health.
For now, researchers said the latest trial should be viewed as an early indication rather than definitive evidence.
Larger randomized controlled trials involving more participants, longer treatment periods and tighter control of potentially confounding factors will be needed to determine whether daily kombucha consumption produces a reliable and lasting blood pressure benefit.
Those studies could also help determine which individuals are most likely to respond, what amount of kombucha might be effective and which components of the beverage are responsible for any observed effect.
Until those questions are answered, researchers and independent health professionals cautioned against considering kombucha a substitute for prescribed blood pressure medications, established dietary recommendations or other proven lifestyle measures.
The current findings instead provide a basis for further investigation into whether the centuries-old fermented tea could eventually have a supporting role in broader cardiovascular health strategies.
Explainer Infographic
Comments